PIP-199

N/A

Report date: 2023/08/10 17:41:48
NME

Base Information

Drug NamePIP-199
Drug Alias NamePIP-199
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFANCM and RMI interaction inhibitor
TargetsFanconi anemia group A proteinRecQ-mediated genome instability protein
Therapy Area/IndicationsBloom SyndromeFanconi Anemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity of Sydney
China Registration ClassN/A

Develop Information

Active CompaniesUniversity of Sydney
Inactive CompaniesN/A
Active IndicationsBloom SyndromeFanconi Anemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A